Categories
Pharmaceutical

Global Sales Of Immunoassays Is Set To Register Impressive Growth Expanding At A Healthy 6.0% CAGR By 2026| Fact.MR Study

Immunoassay Market Analysis, By Technology (Chemiluminescence Immunoassay, Enzyme-linked Immunosorbent Assay, Enzyme Linked Fluorescence Assay, Radioimmunoassay), By Product (Analyzer, Consumables), By Application-Global Market Insights 2026

Intense developments in the field of genomics and proteomics has expanded the database of biomarkers used by industry players to develop new assays that cascade the onset of a disease or disorder. The global immunoassays market is set to register impressive growth, expanding at a healthy 6.0% CAGR By 2026.

To remain ‘ahead’ of your competitors, request a sample:

https://www.factmr.com/connectus/sample?flag=S&rep_id=4766

Prominent Key players of the Immunoassay market survey report:

  • DiaSorin S.p.A.
  • Sysmex Corporation
  • bioMerieux SA
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • Becton
  • Dickinson and Company
  • Merck KGaA.

Speak To Research Analyst For Detailed Insights:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=4766

Global Immunoassays: Market Segmentation

Fact.MR has studied the global immunoassays market with detailed segmentation on the basis of technology, product, application, end-user, and region.

  • By Technology :
    • Chemiluminescence Immunoassay (CLIA)
    • Enzyme-linked Immunosorbent Assay (ELISA)
    • Enzyme Linked Fluorescence Assay (ELFA)
    • Radioimmunoassay (RIA)
    • Others
  • By Product :

    • Analyzer
    • Consumables
  • By Application :

    • Infectious Diseases
    • Endocrinology
    • Oncology
    • Cardiology
    • Orthopedics
    • Others
  • By End-user :

    • Hospitals & Diagnostic Laboratories
    • Blood Banks
    • Others (Pharmaceutical & Biotech Companies, Academic & Research Institutes, Forensic Labs, etc.)
  • By Region :

    • North America
    • Europe
    • Asia Pacific
    • Eastern Europe
    • Latin America
    • Middle East & Africa (MEA)

The insights for each vendor consists of:

  • Company profile
  • SWOT analysis
  • Main market information
  • Market share
  • Revenue, pricing and gross margin

What insights does the Immunoassay Market report provide to the readers?

  • Immunoassay fragmentation on the basis of product type, end use, and region.
  • Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.
  • Collaborations, R&D projects, acquisitions, and product launches of each Immunoassay player.
  • Various regulations imposed by the governments on the consumption of Immunoassay in detail.
  • Impact of modern technologies, such as big data & analytics, artificial intelligence, and social media platforms on the global Immunoassay.

Full Access of this Report Is Available at:

https://www.factmr.com/checkout/4766

The report covers following Immunoassay Market insights and assessment that are helpful for all participants involved in the Immunoassay market:

  • Data on recently introduced regulations and their impact on key industries and on demand in Immunoassay
  • Latest industry Analysis on Immunoassay Market, with key analysis of market drivers, trends, and influencing factors
  • Key trends Analysis of Immunoassay Market and changing consumer preferences in major industries.
  • Changing Immunoassay demand and consumption of diverse products
  • Major trends underlining funding by key investors in numerous countries
  • New investment opportunities in diverse technology and product or service types
  • Comprehensive data and Competitive analysis of Immunoassay major players
  • Immunoassay Market sales in US will grow at a steady pace, driven by growing consumer confidence and economic recovery
  • Immunoassay demand forecast in Europe remains stable, as many countries such as UK, France, and Germany focus on boosting growth

Questionnaire answered in the Immunoassay Market report include:

  • How the market for Immunoassay has grown?
  • What is the present and future outlook of the global Immunoassay on the basis of region?
  • What are the challenges and opportunities for the Immunoassay?
  • Why the consumption of Immunoassay highest in region?
  • In which year segment is expected to overtake segment?

Read Our Latest Article on Healthcare Domain 

https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

contact:

21st floor , 136 Sejong-daero,
Seoul,100-768
South Korea
Phone: +1 (628) 251-1583
Email: sales@factmr.com

Categories
Pharmaceutical

Demand for Radioimmunoassay (RIA) Is Poised to Register a Positive Growth Trend, Expanding at a CAGR of 6.0% | Report Fact.MR

According to Fact.MR’s Study, As the number of chronic and infectious diseases compound, medical advancements have grown in equal proportion. The global Demand for immunoassays is poised to register a positive growth trend, expanding at a CAGR of 6.0% throughout the forecast period (2020-2026).

Medical practitioners are increasingly relying on analyzer technique such as enzyme-linked immunosorbent assay (ELISA), immunofluorescent assay (IFA) and chemiluminescence immunoassay (CLIA) to detect infectious pathogens.

The novel coronavirus pandemic is an area where the immunoassay market shows promising developments. Key players have been conducting extensive research with the onset of the disease to determine possible antibodies to counter the virus. For instance, in April 2020, Bio-Rad Corporation announced the introduction of a blood-based immunoassay kit for the identification of antibodies for coronavirus. Besides, diagnosis of autoimmune diseases has also found increased applications of immunoassay treatments.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4766

“The global immunoassay market is poised to register positive growth in the future, burgeoned by increasing adoption of testing against the backdrop of rising prevalence of chronic and infectious diseases. In addition, the coronavirus pandemic is anticipated to provide further stimulus to the immunoassay testing market,” concludes a Fact.MR analyst.

Key Takeaways of Global Immunoassay Market Study:

  • By technology, chemiluminescence immunoassay (CLIA) shall capture nearly half of the global immunoassay market during the forecast period, expanding at a CAGR of 6.6% across the forecast period. Following behind is the enzyme-linked immunosorbent assay (CLIA), accounting for more than 30% of the market.
  • By product, the consumables segment shall capture greater than 4/5th of the global immunoassay market. Wide usage of immunoassays in diagnosing infectious diseases and endocrine disorders is driving the consumables segment growth.
  • By application, both endocrinal disorders and infectious diseases segment shall expand at a CAGR of 6.5% each, capturing 17.1% and 29.3% market shares respectively. Widespread applications of endocrinal testing for several disorders shall leverage growth prospects for endocrinal disorders while the ongoing COVID-19 pandemic is leveraging the infectious diseases segment.
  • By end-user, hospitals are anticipated to capture the majority of the market share (~81%) while blood banks shall expand the fastest, at a CAGR of nearly 7.0%. Increasing number of immunoassay tests in hospital settings is anticipated to drive the hospitals segment while increased demand for blood transfusions for curing infectious diseases is anticipated to leverage the blood banks segment.
  • By region, North America shall remain the supreme leader, accounting for nearly two-fifths of the global immunoassay market. However, Asia-Pacific promises to offer lucrative opportunities, expanding at a CAGR of 7.0%. Mergers and acquisitions among leading manufacturers and burgeoning investments in the life sciences and healthcare industry are key growth determinants in both regions.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4766

Global Immunoassay Market: Segmentation

Technology

  • Chemiluminescence Immunoassay (CLIA)
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Enzyme Linked Fluorescence Assay (ELFA)
  • Radioimmunoassay (RIA)
  • Others

Product

  • Analyzer
  • Consumables

Application

  • Infectious Diseases
  • Endocrinology
  • Oncology
  • Cardiology
  • Orthopedics
  • Others

End-user

  • Hospitals & Diagnostic Laboratories
  • Blood Banks
  • Others (Pharmaceutical & Biotech Companies, Academic & Research Institutes, Forensic Labs, etc.)

Following Questions Answers Covered in the Report are:

  • How will the global Immunoassay Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Immunoassay Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Immunoassay Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4766

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights –https://www.biospace.com/article/increased-awareness-about-women-health-is-key-for-driving-global-conjugated-estrogen-market/

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Global Immunoassay Market: Competition Structure:

The global immunoassay market is highly consolidated. The top four market players constitute more than half of the total market share. These players are: F. Hoffmann La-Roche Ltd. (Roche Holdings AG), Abbott Laboratories, Siemens Healthineers and Beckman Coulter, Inc. (Danaher).

These players have consolidated their operations by virtue of important collaborations to burgeon production of immunoassay kits. La-Roche, for instance, offers products such as the COBAS C 702 & E 602 Module, the COBAS 4000 & 6000 Analyzer series and Elecsys Assays.

Likewise, Abbott Laboratories offers biotin-free assays to prevent interference in testing and the resulting inaccuracies. Other prominent immunoassay players include DiaSorin S.p.A., Sysmex Corporation, bioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company and Merck KGaA.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com